Try our Advanced Search for more refined results

Life Sciences Cos. Faced 65% More Securities Suits In 2012

By Max Stendahl (March 22, 2013, 1:39 PM EDT) -- Securities fraud class actions against life sciences companies increased almost 65 percent in 2012, and firms may be forced to pay out larger settlements in the wake of the U.S. Supreme Court's Amgen decision lowering the bar for investor suits, according to a Dechert LLP survey released Friday....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!